Ulcerative colitis in children: medical management

David A Gremse1, Karen D Crissinger

  • 1Division of Pediatric Gastroenterology and Nutrition, University of South Alabama College of Medicine, #5321, 1504 Springhill Avenue, Mobile, AL 36604, USA. dgremse@usouthal.edu

Paediatric Drugs
|November 15, 2002
PubMed

Insights

Ulcerative colitis is a chronic inflammatory bowel disease affecting the colon. Treatment focuses on managing symptoms and preventing relapses using medications or surgery, while considering growth and development in pediatric patients.

Area of Science:

  • Gastroenterology
  • Pediatric Gastroenterology
  • Immunology

Background:

  • Ulcerative colitis (UC) is a chronic, relapsing inflammatory disorder of the colonic mucosa with unknown etiology.
  • The inflammation typically affects a continuous segment of the bowel, starting in the rectum.
  • Management aims to control symptoms and prevent disease flares due to the unknown cause.

Purpose of the Study:

  • To review current therapeutic strategies for ulcerative colitis, particularly in pediatric patients.
  • To discuss the role of various immunomodulators in managing pediatric ulcerative colitis.
  • To highlight the comprehensive care needs of children with UC, including growth and development.

Main Methods:

  • Review of existing literature on ulcerative colitis treatment.
  • Analysis of therapeutic agents including 5-aminosalicylates, corticosteroids, and various immunomodulators.
  • Consideration of surgical interventions like colectomy for refractory cases.

Main Results:

  • 5-aminosalicylates and corticosteroids are primary treatments for ulcerative colitis.
  • Immunomodulators (mercaptopurine, azathioprine, methotrexate, cyclosporine, tacrolimus) are increasingly used in pediatric UC.
  • Colectomy is reserved for severe cases unresponsive to medical management.

Conclusions:

  • Therapeutic strategies for ulcerative colitis focus on modulating inflammation to control symptoms and prevent relapses.
  • Pediatric ulcerative colitis management requires balancing symptom control, growth, and development against treatment risks.
  • The decision between long-term medical therapy and surgery involves careful risk-benefit assessment for children and adolescents.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD: